Concepts (148)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 5 | 2022 | 199 | 1.580 |
Why?
|
| Fertility Preservation | 4 | 2021 | 150 | 1.350 |
Why?
|
| Embryo Transfer | 4 | 2023 | 83 | 1.140 |
Why?
|
| Reproductive Techniques, Assisted | 4 | 2021 | 101 | 0.940 |
Why?
|
| Cryopreservation | 3 | 2021 | 175 | 0.920 |
Why?
|
| Embryo Implantation | 2 | 2023 | 278 | 0.800 |
Why?
|
| Ovulation Induction | 1 | 2021 | 62 | 0.770 |
Why?
|
| Infertility, Female | 3 | 2017 | 217 | 0.770 |
Why?
|
| Pregnancy, Twin | 1 | 2021 | 118 | 0.740 |
Why?
|
| Preimplantation Diagnosis | 1 | 2020 | 47 | 0.720 |
Why?
|
| Embryonic Development | 1 | 2020 | 306 | 0.640 |
Why?
|
| Oocytes | 1 | 2020 | 414 | 0.630 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 621 | 0.610 |
Why?
|
| Ovary | 2 | 2021 | 668 | 0.590 |
Why?
|
| Ovariectomy | 1 | 2018 | 330 | 0.580 |
Why?
|
| Anemia, Aplastic | 1 | 2018 | 214 | 0.570 |
Why?
|
| Therapies, Investigational | 1 | 2016 | 62 | 0.560 |
Why?
|
| Peritoneum | 1 | 2017 | 150 | 0.560 |
Why?
|
| Prenatal Diagnosis | 1 | 2020 | 590 | 0.540 |
Why?
|
| Uterus | 3 | 2017 | 678 | 0.540 |
Why?
|
| Infertility | 1 | 2017 | 123 | 0.520 |
Why?
|
| Pregnancy | 14 | 2023 | 7573 | 0.500 |
Why?
|
| Fertility | 1 | 2017 | 336 | 0.480 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 1439 | 0.480 |
Why?
|
| Genetic Testing | 1 | 2020 | 1589 | 0.410 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 573 | 0.400 |
Why?
|
| Placenta Previa | 2 | 2021 | 61 | 0.370 |
Why?
|
| Placenta Accreta | 2 | 2021 | 122 | 0.340 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 1202 | 0.330 |
Why?
|
| Chemoradiotherapy | 1 | 2017 | 1946 | 0.310 |
Why?
|
| Laparoscopy | 1 | 2017 | 1225 | 0.310 |
Why?
|
| Pregnancy Outcome | 3 | 2020 | 643 | 0.290 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2022 | 419 | 0.280 |
Why?
|
| Pregnancy Rate | 2 | 2023 | 58 | 0.270 |
Why?
|
| Fibromyalgia | 1 | 2022 | 12 | 0.220 |
Why?
|
| Female | 23 | 2023 | 141928 | 0.220 |
Why?
|
| Abortion, Spontaneous | 1 | 2022 | 112 | 0.200 |
Why?
|
| Fertilization | 1 | 2021 | 56 | 0.200 |
Why?
|
| Superovulation | 1 | 2020 | 14 | 0.200 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 35 | 0.190 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 198 | 0.190 |
Why?
|
| Blastocyst | 1 | 2020 | 124 | 0.190 |
Why?
|
| Maternal Age | 2 | 2017 | 152 | 0.180 |
Why?
|
| Maternal Mortality | 1 | 2020 | 77 | 0.180 |
Why?
|
| Pregnancy Trimester, First | 1 | 2020 | 127 | 0.180 |
Why?
|
| Endometrium | 1 | 2023 | 470 | 0.170 |
Why?
|
| Aneuploidy | 1 | 2020 | 369 | 0.170 |
Why?
|
| Retrospective Studies | 7 | 2023 | 37905 | 0.160 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 394 | 0.160 |
Why?
|
| Cesarean Section | 1 | 2020 | 367 | 0.150 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2017 | 24 | 0.150 |
Why?
|
| Adult | 9 | 2021 | 77950 | 0.140 |
Why?
|
| Mullerian Ducts | 1 | 2017 | 76 | 0.140 |
Why?
|
| Influenza Vaccines | 1 | 2021 | 635 | 0.140 |
Why?
|
| Contraceptive Agents, Female | 1 | 2016 | 38 | 0.140 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 101 | 0.140 |
Why?
|
| Humans | 21 | 2023 | 261506 | 0.140 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2016 | 167 | 0.130 |
Why?
|
| Leiomyoma | 1 | 2016 | 145 | 0.130 |
Why?
|
| Neoplasms | 2 | 2018 | 15193 | 0.130 |
Why?
|
| Choice Behavior | 1 | 2016 | 226 | 0.120 |
Why?
|
| Organ Transplantation | 1 | 2017 | 191 | 0.120 |
Why?
|
| Influenza, Human | 1 | 2021 | 925 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 260 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2016 | 215 | 0.120 |
Why?
|
| Fallopian Tubes | 1 | 2014 | 119 | 0.120 |
Why?
|
| Aromatase Inhibitors | 1 | 2016 | 305 | 0.120 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2014 | 72 | 0.110 |
Why?
|
| Infant, Newborn | 3 | 2021 | 8223 | 0.110 |
Why?
|
| Androgens | 1 | 2016 | 511 | 0.110 |
Why?
|
| Premature Birth | 1 | 2017 | 407 | 0.110 |
Why?
|
| Germ Cells | 1 | 2014 | 335 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 651 | 0.100 |
Why?
|
| Cancer Care Facilities | 1 | 2016 | 884 | 0.100 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 715 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 1303 | 0.100 |
Why?
|
| Uterine Neoplasms | 1 | 2016 | 545 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2016 | 899 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 761 | 0.090 |
Why?
|
| DNA Methylation | 1 | 2020 | 2669 | 0.090 |
Why?
|
| Tissue Survival | 2 | 2021 | 15 | 0.090 |
Why?
|
| Patient Selection | 1 | 2016 | 2055 | 0.080 |
Why?
|
| Young Adult | 4 | 2020 | 21445 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 3719 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1697 | 0.070 |
Why?
|
| Morphine Derivatives | 1 | 2022 | 9 | 0.060 |
Why?
|
| Live Birth | 1 | 2022 | 56 | 0.050 |
Why?
|
| United States | 2 | 2017 | 15433 | 0.050 |
Why?
|
| Pandemics | 2 | 2022 | 1559 | 0.050 |
Why?
|
| Fibrin | 1 | 2022 | 82 | 0.050 |
Why?
|
| Intention | 1 | 2021 | 109 | 0.050 |
Why?
|
| Animals | 3 | 2021 | 59536 | 0.050 |
Why?
|
| Sheep | 1 | 2021 | 258 | 0.050 |
Why?
|
| Iran | 1 | 2020 | 68 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 4314 | 0.040 |
Why?
|
| Mice | 1 | 2020 | 34495 | 0.040 |
Why?
|
| Adolescent | 2 | 2016 | 31252 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2022 | 611 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2017 | 32848 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2022 | 9244 | 0.040 |
Why?
|
| Middle Aged | 4 | 2020 | 86204 | 0.040 |
Why?
|
| Placenta | 1 | 2022 | 516 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 610 | 0.040 |
Why?
|
| Reproductive Health Services | 1 | 2016 | 16 | 0.040 |
Why?
|
| Child | 1 | 2018 | 29154 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 181 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 672 | 0.040 |
Why?
|
| Estrenes | 1 | 2016 | 24 | 0.040 |
Why?
|
| Estrogen Receptor Antagonists | 1 | 2016 | 9 | 0.040 |
Why?
|
| Norpregnadienes | 1 | 2016 | 4 | 0.040 |
Why?
|
| Contraceptives, Oral, Combined | 1 | 2016 | 21 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2021 | 1914 | 0.030 |
Why?
|
| Tea | 1 | 2016 | 43 | 0.030 |
Why?
|
| Uterine Myomectomy | 1 | 2016 | 14 | 0.030 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2016 | 55 | 0.030 |
Why?
|
| Intrauterine Devices, Medicated | 1 | 2016 | 32 | 0.030 |
Why?
|
| Levonorgestrel | 1 | 2016 | 49 | 0.030 |
Why?
|
| Mifepristone | 1 | 2016 | 147 | 0.030 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2016 | 48 | 0.030 |
Why?
|
| Incidence | 2 | 2017 | 5673 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 208 | 0.030 |
Why?
|
| Vaccination | 1 | 2021 | 1123 | 0.030 |
Why?
|
| Curcumin | 1 | 2016 | 117 | 0.030 |
Why?
|
| Vitamins | 1 | 2016 | 157 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 2316 | 0.030 |
Why?
|
| Oximes | 1 | 2016 | 175 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2016 | 145 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 527 | 0.030 |
Why?
|
| HELLP Syndrome | 1 | 2014 | 20 | 0.030 |
Why?
|
| Fetal Monitoring | 1 | 2014 | 50 | 0.030 |
Why?
|
| Vitamin D | 1 | 2016 | 261 | 0.030 |
Why?
|
| Graft Survival | 1 | 2017 | 1062 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 1371 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 4298 | 0.030 |
Why?
|
| Estradiol | 1 | 2016 | 748 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2017 | 787 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 2522 | 0.030 |
Why?
|
| Risk Factors | 2 | 2020 | 17523 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 212 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 395 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2016 | 1392 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 1085 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2016 | 735 | 0.020 |
Why?
|
| Infant | 1 | 2022 | 13310 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1870 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 4320 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 4975 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 15694 | 0.010 |
Why?
|